TL;DR
This paper reveals how mechanical forces, like those experienced in blood flow, cause the von Willebrand factor (VWF) A2 domain to unfold, exposing its cleavage site to the enzyme ADAMTS13. This force-sensing mechanism is crucial for regulating VWF multimer size, preventing pathological platelet aggregation, and understanding bleeding disorders.
What Problem Does This Paper Address?
Von Willebrand factor (VWF) is a critical protein for blood clotting, forming large multimers that are essential for platelet adhesion. However, these ultra-large VWF (ULVWF) multimers can lead to dangerous platelet aggregation if not properly regulated. The enzyme ADAMTS13 cleaves VWF to control its size, and this process is known to be dependent on shear flow in blood vessels. While it was understood that shear stress influences VWF cleavage, the precise molecular mechanism by which VWF's A2 domain, the target of ADAMTS13, becomes activated under these conditions remained elusive. Specifically, the A2 domain's cleavage site is thought to be buried in its native, folded state, so how mechanical forces expose it for enzymatic action was a key question.
Methods
The researchers employed a combination of computational and experimental techniques:
- Molecular Dynamics (MD) Simulations: They used MD simulations to model the behavior of the VWF A2 domain under tensile stress. This involved applying pulling forces to the protein termini to mimic the stretching experienced in shear flow.
- Force Distribution Analysis (FDA): This computational method was used to map how the applied mechanical force propagates through the protein's structure, identifying regions of high strain.
- Homology Modeling: A 3D model of the VWF A2 domain was constructed based on existing crystal structures of related VWF domains.
- In Vitro Mutagenesis: Specific mutations were introduced into the VWF A2 domain to mimic disulfide bonds found in other VWF domains (A1 and A3) that confer force resistance. This was done to test the hypothesis that locking the A2 domain could prevent unfolding.
- Electrophoretic Analysis: Techniques like multimer analysis were used to assess the structural integrity and cleavage susceptibility of wild-type and mutant VWF proteins.
Datasets
Not discussed in the paper. The study primarily relies on computational modeling and experimental validation of engineered protein variants.
Key Insights and Ideas
- Force-Induced Unfolding is Key: The central finding is that mechanical force, not just chemical denaturation, directly causes the VWF A2 domain to unfold. This unfolding is a stepwise process, primarily affecting the C-terminal half of the domain.
- The "Knotted" Rossman Fold: The A2 domain possesses a unique "knotted" Rossman fold in its N-terminal half, which is significantly more resistant to unfolding than the classical Rossman fold of the C-terminal half. This differential stability is crucial for selective unfolding.
- Selective Exposure of the Cleavage Site: The unfolding mechanism specifically exposes the ADAMTS13 cleavage site (Y1605-M1606) while leaving other parts of the domain intact. This ensures that only the cleavage site is targeted by ADAMTS13.
- Disulfide Bonds Confer Force Resistance: The A1 and A3 domains of VWF have disulfide bonds that lock them in a stable, folded state, making them resistant to mechanical unfolding. The researchers hypothesized that introducing a similar disulfide bond into the A2 domain would similarly lock it.
- Mutant A2 is ADAMTS13-Resistant: A mutant A2 domain engineered with a disulfide bond was found to be resistant to cleavage by ADAMTS13 in vitro, supporting the hypothesis that locking the domain prevents unfolding and activation.
Key Results
- MD simulations showed that applying forces of around 500 pN can lead to the unfolding of the VWF A2 domain.
- Force distribution analysis revealed that mechanical strain propagates through the beta-sheet structure of the A2 domain, with the N-terminal beta-strand (β1) acting as a force-bearing element.
- The cleavage site residue Y1605 experiences high strain due to interactions with neighboring residues in the central beta-strands, even in the folded state.
- A mutant VWF with an engineered disulfide bond in the A2 domain (N1493C/C1670S) showed significantly reduced electrophoretic mobility, indicating a more compact, disulfide-bonded structure.
- This mutant A2 VWF was completely resistant to ADAMTS13 proteolysis in vitro, unlike wild-type VWF.
Limitations and Future Work
- In Silico vs. In Vivo: The simulations were performed on a truncated A2 domain and at forces that might be higher than those experienced by average-sized VWF multimers in vivo. Future work should involve simulating the full A1-A2-A3 construct to account for inter-domain interactions.
- Understanding Physiological Forces: Further investigation is needed to precisely correlate the forces observed in simulations with the forces experienced by VWF multimers of different sizes under physiological flow conditions.
- Inhibitor Design: The authors suggest that understanding the cleavage-activated conformation of A2 provides a structural basis for designing inhibitors for VWF type 2 diseases, which are characterized by enhanced VWF cleavage. This is a promising avenue for future research.
- Role of the N-terminal Domain: The paper hypothesizes that the force-resistant N-terminal "knotted" Rossman fold of A2 might play a role in inhibiting VWF's interaction with platelets, preventing unwanted aggregation. This warrants further investigation.
Summary updated